Many healthcare executives are applauding the list of additional drugs chosen for the Medicare Drug Price Negotiation Program, while some drug companies are opposing it.
The post How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program appeared first on MedCity News.
